Therapy Industry in France: Market Research Reports, Statistics and Analysis

Company Report: Immunotherapy In France For Year 2012

... Such as severe rhinoconjunctivitis and rhinitis, as well as allergic asthma. The seventh largest pharmaceutical company in france and the leader in sublingual immunotherapy treatment, stallergenes devotes almost ...

Company Report: Therapeutics In The United States And France For ...

... With the industrialization of its technologies in order to develop its commercial offering for therapeutics and biopharmaceutical products and services, while adopting stringent cost control measures. For 2012 ...

Company Report: Therapeutics In The United States And France For ...

... Increase in commercial opportunities. These developments are being accompanied by major technological advances, enabling us to accelerate the rollout of our therapeutics programs. In line with our ...

Company Report: Immunotherapy In France For Year 2012

... Such as severe rhinoconjunctivitis and rhinitis, as well as allergic asthma. The seventh largest pharmaceutical company in france and the leader in sublingual immunotherapy treatment, stallergenes devotes almost ...

Meda Ab - Company Report For Year 2012

... Of the disease is very important for ar patients, and dymista fulfils this need since it is, to date, the most effective therapy regardless of disease severity. Dymista represents a significant advance in ar ...

Cancer And Beds Market In Italy And France

Cancer Profile In Western Europe

Pharmaceutical Industry Market In United Kingdom And France

Therapy Market In The United States And France

... Objectives a73 assess temporal changes in the adherence to evidence-based therapies in 2.5 Million patients with stemi and nstemi since 1990 a73 determine if previously reported disparities in care ...